Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

por García-Grimshaw, Miguel, Ceballos-Liceaga, Santa Elizabeth, Hernández-Vanegas, Laura E., Núñez, Isaac, Hernández-Valdivia, Noé, Carrillo-García, Daniel Amado, Michel-Chávez, Anaclara, Galnares-Olalde, Javier Andrés, Carbajal-Sandoval, Guillermo, del Mar Saniger-Alba, María, Carrillo-Mezo, Roger A., Fragoso-Saavedra, Sergio, Espino-Ojeda, Alba, Blaisdell-Vidal, Carlos, Mosqueda-Gómez, Juan Luis, Sierra-Madero, Juan, Pérez-Padilla, Rogelio, Alomía-Zegarra, José Luis, López-Gatell, Hugo, Díaz-Ortega, José Luis, Reyes-Terán, Gustavo, Arauz, Antonio, Valdés-Ferrer, Sergio Iván
Publicado 2021